Form 4: Labcorp Executive Caveney Reports Stock Transactions
Insider Transaction Report
Labcorp Holdings Inc. EVP Brian J. Caveney reported multiple transactions involving common stock and Restricted Stock Units, including acquisitions from RSU vesting and dispositions for tax withholding.
Summary
- Brian J. Caveney, EVP, President of ED, CMO & CSO of Labcorp Holdings Inc., reported several transactions in the company's common stock and Restricted Stock Units (RSUs).
- On February 6, 2026, Caveney acquired 670 shares of common stock upon the vesting of RSUs and disposed of 209 shares at $277.20 for tax withholding purposes.
- On February 7, 2026, Caveney acquired a total of 628 shares (517 + 111) of common stock from RSU vesting.
- On February 9, 2026, Caveney disposed of a total of 180 shares (148 + 32) at $274.01 for tax withholding purposes.
- Following these transactions, Caveney's direct beneficial ownership of common stock was 31,077.9234 shares.
- The reported beneficial ownership of common stock includes 57.1306 shares acquired on June 30, 2025, and 45.1355 shares acquired on December 31, 2025, through employee stock purchase plans.
- Caveney holds an aggregate of 2,890 Restricted Stock Units following these transactions.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive filing. While there are dispositions, they are for tax withholding, which is a standard practice. The underlying acquisitions are due to RSU vesting, indicating the executive's continued equity accumulation as part of their compensation.
Positives
- Acquisition of 670 shares of common stock on February 6, 2026, from RSU vesting.
- Acquisition of 517 shares of common stock on February 7, 2026, from RSU vesting.
- Acquisition of 111 shares of common stock on February 7, 2026, from RSU vesting.
- The vesting of Restricted Stock Units indicates continued long-term incentive compensation for the executive.
Negatives
- Disposition of 209 shares of common stock on February 6, 2026, at $277.20 to satisfy tax withholding obligations.
- Disposition of 148 shares of common stock on February 9, 2026, at $274.01 to satisfy tax withholding obligations.
- Disposition of 32 shares of common stock on February 9, 2026, at $274.01 to satisfy tax withholding obligations.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transaction filings like this Form 4 are routine disclosures required by the SEC, providing transparency into executive stock ownership changes. While not indicative of broader industry trends, they offer insights into executive compensation and confidence in the company's stock.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Brian J. Caveney granted a Power of Attorney to Kathryn W. Kyle, authorizing her to execute and file Forms 3, 4, and 5 on his behalf in accordance with Section 16(a) of the Securities Exchange Act of 1934. | 2026-01-19 | Streamlines the process for executive compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate filings. |
Stakeholder Impact
- Shareholders: Provides transparency regarding executive stock ownership and compensation structure.
- Employees: Reflects the company's executive compensation practices, including equity incentives.
Key Dates
| Date | Description |
|---|---|
| 2024-02-07 | Start of three equal annual installments for vesting of certain Restricted Stock Units, now fully vested. |
| 2025-02-06 | Start of three equal annual installments for vesting of certain Restricted Stock Units. |
| 2025-06-30 | Acquisition of 57.1306 shares under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan. |
| 2025-12-31 | Acquisition of 45.1355 shares under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan. |
| 2026-01-19 | Effective date of the Power of Attorney granted by Brian J. Caveney to Kathryn W. Kyle. |
| 2026-02-06 | Acquisition of 670 shares of common stock from RSU vesting and disposition of 209 shares for tax withholding. |
| 2026-02-07 | Acquisition of 517 shares and 111 shares of common stock from RSU vesting. |
| 2026-02-09 | Disposition of 148 shares and 32 shares of common stock for tax withholding. |
| 2026-02-10 | Date the Form 4 was signed by Kathryn W. Kyle, Attorney-in-Fact. |
Recommendation
holdThe filing details routine insider transactions related to executive compensation, specifically RSU vesting and subsequent tax-related dispositions. These are expected events and do not indicate a change in the company's fundamental outlook or the executive's confidence beyond the standard compensation structure. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to warrant a change in investment thesis.
Keywords
Labcorp Holdings Inc., LH, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, RSU Vesting, Executive Compensation, Brian J. Caveney, Common Stock, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.